Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy

BACKGROUND: Several prognostic models for overall survival (OS) have been developed and validated in men with metastatic castration-resistant prostate cancer (mCRPC) who receive first-line chemotherapy. We sought to develop and validate a prognostic model to predict OS in men who had progressed afte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Halabi, Susan, Lin, Chen-Yen, Small, Eric J., Armstrong, Andrew J., Kaplan, Ellen B., Petrylak, Daniel, Sternberg, Cora N., Shen, Liji, Oudard, Stephane, de Bono, Johann, Sartor, Oliver
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833929/
https://ncbi.nlm.nih.gov/pubmed/24136890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt280
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars